Evidence map›Paper›PMID 26247936›Full record

ArticleInternational journal of molecular sciences2015

Composition, Cytotoxic and Antimicrobial Activities of Satureja intermedia C.A.Mey Essential Oil.

Javad Sharifi-Rad, Mehdi Sharifi-Rad, Seyedeh Mahsan Hoseini-Alfatemi, Marcello Iriti, Majid Sharifi-Rad, Marzieh Sharifi-Rad

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 56 citations in OpenAlex.

  1. Current Knowledge of the GenusPharmaceuticals (Basel, Switzerland) · 2026
    Review
  2. The anticancer effects of thymol on HepG2 cell line.Medical oncology (Northwood, London, England) · 2023
    Article
  3. Review
  4. The Essential Oil fromPharmaceuticals (Basel, Switzerland) · 2022
    Article
  5. Nanoemulsions ofPharmaceutics · 2021
    Article
  6. Review
  7. Article
  8. Article
  9. Pharmaceutics · 2019
    Article
  10. Article
  11. Review
  12. Article
  13. The antibacterial activity of "Dental research journal
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Javad Sharifi-RadZabol Medicinal Plants Research Center, Zabol University of Medical Sciences, Zabol 61615-585, Iran. javad.sharifirad@gmail.com.
Mehdi Sharifi-RadDepartment of Medical Parasitology, Zabol University of Medical Sciences, Zabol 61663-335, Iran. mehdi_sharifirad@yahoo.com.
Seyedeh Mahsan Hoseini-AlfatemiPediatric Infections Research Center, Mofid Children Hospital, Shahid Beheshti University of Medical Sciences, Tehran 15468-15514, Iran. m.hoseinialfatemi@gmail.com.
Marcello IritiDepartment of Agricultural and Environmental Sciences, Milan State University, via G. Celoria 2, Milan 20133, Italy. marcello.iriti@unimi.it.
Majid Sharifi-RadDepartment of Range and Watershed Management, Faculty of Natural Resources, University of Zabol, Zabol 98615-538, Iran. majid.sharifirad@gmail.com.
Marzieh Sharifi-RadDepartment of Chemistry, Faculty of Science, University of Zabol, Zabol 98615-538, Iran. marzieh.sharifirad@gmail.com.
Zabol University · IRShahid Beheshti University of Medical Sciences · IRUniversity of Milan · ITZabol University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, the essential oil (EO) constituents from the aerial parts of Satureja intermedia C.A.Mey were detected by GC and GC/MS. The antimicrobial activity of EO on oral pathogens and its cytotoxicity to human cancer cells were determined by the microbroth dilution method and the crystal violet staining method, respectively. Thirty-nine compounds were identified and the main EO constituents were γ-terpinene (37.1%), thymol (30.2%), p-cymene (16.2%), limonene (3.9%), α-terpinene (3.3%), myrcene (2.5%), germacrene B (1.4%), elemicine (1.1%) and carvacrol (0.5%). The S. intermedia EO showed a concentration-dependent decrease in viability of Hep-G2 (hepatocellular carcinoma) and MCF-7 (breast adenocarcinoma) human cancer cell lines (p < 0.05). Antimicrobial screening of S. intermedia EO demonstrated slight antibacterial and antifungal activities against Streptococcus mutants, S. salivarius, Enterococcus faecalis, Staphylococcus aureus, Candida albicans and C. glabrata. Further preclinical studies are needed to assess the efficacy and safety of S. intermedia EO as a new promising anticancer agent.

Indexed as

Antifungal AgentsAnti-Infective AgentsAntineoplastic AgentsCandidaHep G2 CellsHumansLamialesMCF-7 CellsOils, VolatileTerpenesAntifungal AgentsAnti-Infective AgentsAntineoplastic AgentsOils, VolatileTerpenesbreast adenocarcinomaC/MShepatocellular carcinomahuman cancer cellsoral pathogens

Identifiers

PMID26247936
PMCPMC4581223
OpenAlexW1944948122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.